These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20222865)

  • 1. Cyclodextrins: an overview of the complexation of pharmaceutical proteins.
    Varca GH; Andréo-Filho N; Lopes PS; Ferraz HG
    Curr Protein Pept Sci; 2010 Jun; 11(4):255-63. PubMed ID: 20222865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical techniques for characterization of cyclodextrin complexes in aqueous solution: a review.
    Mura P
    J Pharm Biomed Anal; 2014 Dec; 101():238-50. PubMed ID: 24680374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclodextrins in pharmaceutical formulations II: solubilization, binding constant, and complexation efficiency.
    Jambhekar SS; Breen P
    Drug Discov Today; 2016 Feb; 21(2):363-8. PubMed ID: 26687191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphiphilic cyclodextrin nanoparticles.
    Varan G; Varan C; Erdoğar N; Hıncal AA; Bilensoy E
    Int J Pharm; 2017 Oct; 531(2):457-469. PubMed ID: 28596142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggregation of cyclodextrins as an important factor to determine their complexation behavior.
    Bikádi Z; Kurdi R; Balogh S; Szemán J; Hazai E
    Chem Biodivers; 2006 Nov; 3(11):1266-78. PubMed ID: 17193241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization.
    Loftsson T; Brewster ME
    J Pharm Sci; 1996 Oct; 85(10):1017-25. PubMed ID: 8897265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supramolecular polymeric materials via cyclodextrin-guest interactions.
    Harada A; Takashima Y; Nakahata M
    Acc Chem Res; 2014 Jul; 47(7):2128-40. PubMed ID: 24911321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclodextrin containing biodegradable particles: from preparation to drug delivery applications.
    Zafar N; Fessi H; Elaissari A
    Int J Pharm; 2014 Jan; 461(1-2):351-66. PubMed ID: 24342710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Functionalization of Cyclodextrin Derivatives to Create Supramolecular Pharmaceutical Materials].
    Osaki M
    Yakugaku Zasshi; 2019; 139(2):165-173. PubMed ID: 30713225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring versatile applications of cyclodextrins: an overview.
    Sharma N; Baldi A
    Drug Deliv; 2016; 23(3):739-57. PubMed ID: 25051096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supramolecular host-guest interaction of trityl-nitroxide biradicals with cyclodextrins: modulation of spin-spin interaction and redox sensitivity.
    Tan X; Song Y; Liu H; Zhong Q; Rockenbauer A; Villamena FA; Zweier JL; Liu Y
    Org Biomol Chem; 2016 Feb; 14(5):1694-701. PubMed ID: 26700002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of cyclodextrins in the formulation of genistein part 1. Preparation and physicochemical properties of genistein complexes with native cyclodextrins.
    Daruházi AE; Szente L; Balogh B; Mátyus P; Béni S; Takács M; Gergely A; Horváth P; Szoke E; Lemberkovics E
    J Pharm Biomed Anal; 2008 Nov; 48(3):636-40. PubMed ID: 18757150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclodextrins in topical drug formulations: theory and practice.
    Loftsson T; Masson M
    Int J Pharm; 2001 Aug; 225(1-2):15-30. PubMed ID: 11489551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclodextrins as Protective Agents of Protein Aggregation: An Overview.
    Oliveri V; Vecchio G
    Chem Asian J; 2016 Jun; 11(11):1648-57. PubMed ID: 27037956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic Macromolecular Material Design-The Versatility of Cyclodextrin-Based Host-Guest Chemistry.
    Schmidt BVKJ; Barner-Kowollik C
    Angew Chem Int Ed Engl; 2017 Jul; 56(29):8350-8369. PubMed ID: 28245083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural background of cyclodextrin-protein interactions.
    Aachmann FL; Otzen DE; Larsen KL; Wimmer R
    Protein Eng; 2003 Dec; 16(12):905-12. PubMed ID: 14983070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclodextrins in drug delivery.
    Loftsson T; Jarho P; Másson M; Järvinen T
    Expert Opin Drug Deliv; 2005 Mar; 2(2):335-51. PubMed ID: 16296758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclodextrin functionalized graphene nanosheets with high supramolecular recognition capability: synthesis and host-guest inclusion for enhanced electrochemical performance.
    Guo Y; Guo S; Ren J; Zhai Y; Dong S; Wang E
    ACS Nano; 2010 Jul; 4(7):4001-10. PubMed ID: 20583782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Potential of Cyclodextrins as Novel Active Pharmaceutical Ingredients: A Short Overview.
    di Cagno MP
    Molecules; 2016 Dec; 22(1):. PubMed ID: 28029138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin complexation with cyclodextrins by the autoclave process: Method development and characterization of complex formation.
    Hagbani TA; Nazzal S
    Int J Pharm; 2017 Mar; 520(1-2):173-180. PubMed ID: 28167265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.